Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Sorrento Therapeutics, Inc. SRNE

Full chart Compare
Set alert

Price alert · SRNE

All alert types
0.00 USD 0.00 (+0.00%)

At closeNov 6, 2026, 4:00 PM EST

0.009 Day range 0.01
0.0001 52-week range 0.009
YTD
-88.46%
1 year
-96.67%

Revenue & Expenses

Income Tax Benefit → Expenses: $2.42MExpenses → Selling, General & Admin: $182.34MExpenses → Research & Development: $221.23MExpenses → Other Operating Expenses: $130.14MExpenses → Interest Expense: $8.57MExpenses → Other Expenses: $62.37MGross Profit → Expenses: $29.39MRevenue → Gross Profit: $29.39MRevenue → Cost of Revenue: $33.45MNet Loss → Expenses: $572.84MIncome Tax Benefit$2.42MGross Profit$29.39MNet Loss$572.84MCost of Revenue$33.45MExpenses$604.65MSelling, General & Admin$182.34MResearch & Development$221.23MOther Operating Expenses$130.14MInterest Expense$8.57MOther Expenses$62.37MRevenue$62.84M

No annual statement lines

SRNE has no annual lines for this statement.